Open access at Transplantation and Cellular Therapy Journal - International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update seth rotz Neel Bhatt et al sciencedirect.com/science/articl…

Looking forward to sharing perspective on health system readiness for cell gene therapy and #SarahCannon work in this area at #ASGCT2024 (PS: Andre Williams hope ASTCT pin matches with the theme here!?)

Thank you to everyone who attended the 2024 Leadership Course with leaders in the #HCT and #CellularTherapy field. Here we like to amplify diversity, mentorship, sponsorship and build connections to invest in the future of ASTCT!

🚨Hot off the press 👉🏼HUGE MILESTONE in all of #MEDICINE & huge win for patients & families with sickle cell disease & β-Thalassemia
👉🏼TODAY Two back to back papers published with an editorial in the New England Journal of Medicine NEJM on the First Gene Therapies to Treat…

Day 2 of the ASTCT’s Leadership Course is underway! 15 emerging #HCT and cell therapy leaders have the opportunity to gain coaching & career advice from esteemed professionals in the field. ow.ly/HZ6R50RvUee

Happy to be participating in the ASTCT 2024 Leadership course. I’m learning so much from giants in the field of allogeneic transplant. Navneet Majhail, MD, MS Krishna Komanduri, MD, FASTCT Dr. Elizabeth Shpall Corey Cutler

I learnt so much over the last 2 days about running a BMT program. I highly recommend ASTCT Leadership course to mid level BMT faculty considering a leadership role in the future. Excellent opportunity to network with leaders in the field.

Flying home after a spectacular ASTCT leadership course. One of the many enlightening moments was a series of talks and panel discussion about leadership challenges by three hematology and cell therapy masters, Mary Horowitz, Brian J. Bolwell, MD and Fred LeMaistre Sarah Cannon Docs.

What an accomplishment by Haydar Frangoul and Sarah Cannon Docs TriStar Health Children’s Hospital for making significant contributions to Exagamglogene Autotemcel trials for #Thalassemia #SickleCellDisease . Congrats Haydar for back to back papers in NEJM as first & as senior author!!

Leaving ASTCT Leadership Course where we bring new/emerging leaders in #BMT #CellTherapy and discuss foundational aspects of healthcare leadership. 🙏 to faculty/participants + co-chairs Dianna S Howard Dr Cook for sharing their experiences and insights. Future of our field is 👍

Tagraxofusp is a first-in-class CD123-directed drug which has changed the field of #BPDCN . We review the evidence leading to its approval, use in combos and newer CD123 agents.
Wei Ying Jen Naveen Pemmaraju, MD Marina Konopleva MD Anderson Cancer Center #Leukemia
ACS Journal Cancer
doi.org/10.1002/cncr.3…

10 suggested action items for physician colleagues suffering under the burden of American Board of Internal Medicine (ABIM) MOC. #MedTwitter

1. If your institution allows it, stop participating in MOC. Personally, MOC has no value to me.

Congratulations The EBMT for 50 years of supporting and growing the international transplant and cellular therapy community #EBMT24

Thank you Colleen Allen for amplifying #IntersectionalMed and #EquityDiversityInclusion #EBMT24 🏆🙌🏽 I’m honoured and privileged to know these exceptional people! Dr Silvia Montoto Salwa Saadeh Dr Myra Ruka and Navneet Majhail, MD, MS 🙏🏽

🌟 Key insights at #EBMT24 today from Navneet Majhail, MD, MS on our ACCESS Initiative with ASTCT.

'Equitable health care is high-quality health care. In other words, you don't have high-quality in your health care system/setting if it is not equitable.'

“I see lots of quality dashboards, but not one on health inequities” Navneet Majhail, MD, MS
Connecting equity with quality. Great session at #EBMT24

“Equitable healthcare is high quality healthcare” 👏🏽Navneet Majhail, MD, MS always bringing wisdom and spot on perspectives The EBMT #IntersectionalMed #EBMT24 @astct

🙏 The EBMT A/Prof Nada Hamad for inviting me to share ideas on bridging equity with quality in transplant and cellular therapy - and yes, healthcare cannot be high quality without being equitable! #EBMT24

Enjoyed presenting at Optum Health Education event on essentials of oncology and transplant - shared perspectives on #CARTcell updates and the work HCA Healthcare Sarah Cannon Cancer Institute is doing with innovative care models, outpatient CART, and enhancing access

Took a break from clinic to view #Eclipse2024 - Nashville was ☁️ but we got a glimpse of 🌒